Free Trial
LON:KMK

Kromek Group (KMK) Share Price, News & Analysis

Kromek Group logo
GBX 6 +0.00 (+0.05%)
(As of 04:31 AM ET)

About Kromek Group Stock (LON:KMK)

Key Stats

Today's Range
5.90
6.10
50-Day Range
5.40
7.80
52-Week Range
3.82
8.50
Volume
184,655 shs
Average Volume
1.11 million shs
Market Capitalization
£38.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear, CBRNe security, and safety screening markets. The company's products provide high resolution information on material composition and structure that are used in various applications. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection. In addition, the company provides medical imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT systems. Further, it offers CBRNE homeland security products and solutions for government, border control, airport and seaports, HazMat teams, ambulance crews, police, and armed forces, as well as a range of gamma spectroscopy software that enables specialized gamma-ray spectroscopy for the analysis of samples. Additionally, the company provides CZT imaging development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, Australasia, and Africa. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.

Receive KMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kromek Group and its competitors with MarketBeat's FREE daily newsletter.

KMK Stock News Headlines

Kromek Group Announces AGM and Annual Report
2024 Election Year Stocks: Uncover Hidden Gems!
In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.
Kromek Share Chat (KMK)
KRMKF Kromek Group plc
See More Headlines

KMK Stock Analysis - Frequently Asked Questions

Kromek Group's stock was trading at GBX 4.80 on January 1st, 2024. Since then, KMK shares have increased by 25.1% and is now trading at GBX 6.
View the best growth stocks for 2024 here
.

Kromek Group plc (LON:KMK) announced its quarterly earnings results on Wednesday, December, 11th. The company reported ($0.70) EPS for the quarter. Kromek Group had a negative trailing twelve-month return on equity of 8.92% and a negative net margin of 23.25%.

Shares of KMK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kromek Group investors own include Eden Research (EDEN), 4D pharma (DDDD), IQE (IQE), Tullow Oil (TLW), 88 Energy (88E), Active Energy Group (AEG) and AFC Energy (AFC).

Company Calendar

Last Earnings
12/11/2019
Today
11/19/2024

Industry, Sector and Symbol

Industry
Scientific & Technical Instruments
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

Net Income
£-4,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£17.62 million
Cash Flow
GBX 0.71 per share
Book Value
GBX 8 per share

Miscellaneous

Free Float
N/A
Market Cap
£38.51 million
Optionable
Not Optionable
Beta
0.94
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (LON:KMK) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners